Imatinib Mesylate in Treating Patients With Recurrent Meningioma

Clinical trial NCT00045734 · COMPLETED

Trial details

NCT number: NCT00045734
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Grade I Meningioma Adult Grade II Meningioma Adult Grade III Meningioma Adult Meningeal Hemangiopericytoma Adult Meningioma Recurrent Adult Brain Tumor

Start date: 2003-02-01
Primary completion: 2009-12-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.